Table 5.
Distribution of CTLA4 -318 genotypes in Tunisian AIH patients and controls.
| CTLA4 -318 Genotypes | AIH Patients (n = 50) |
Controls (n = 100) |
p | OR (95% CI) | ||
| n | GF (%) | n | GF (%) | |||
| C/C | 47 | 94 | 91 | 91 | 0.75 | – |
| C/T | 3 | 6 | 9 | 9 | 0.75 | – |
| T/T | 0 | 0 | 0 | 0 | 0 | – |
| CTLA 4 (C/T −318) Alleles | AIH Patients |
Controls |
p | OR (95% CI) | ||
| 2n | AF (%) | 2n | AF (%) | |||
| C | 97 | 97 | 191 | 95.5 | 0.75 | |
| T | 3 | 3 | 9 | 4.5 | 0.75 | – |
n: number of subjects, AIH: Autoimmune Hepatitis, GF: Genotype frequency, OR: odds ratio, CI: Confidence interval. P value calculated by the Fisher exact probability test.